Preparation method of osteoarthritis animal model

An animal model, osteoarthritis technology, applied in medical preparations containing active ingredients, pharmaceutical formulations, peptide/protein components, etc. and other problems, to achieve the effect of economy and practicality, convenient material acquisition, and rapid modeling

Inactive Publication Date: 2014-09-24
王维山
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The research on the mechanism of osteoarthritis and intervention measures must be based on animal models. The existing animal models of osteoarthritis are mainly based on joint trauma caused by surgical cutting of the fork ligament, which cannot tru...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0008] Example 1: Intra-articular injection of 1.4 ml of the above-mentioned mixed solution into New Zealand white rabbits, followed by intra-articular injection for 3 days, articular cartilage degeneration begins in 1 week, and a mid-late stage osteoarthritis model can be formed in 3 weeks.

Embodiment 2

[0009] Example 2: 250g SD rats were injected with 0.125ml of the above mixed solution into the joint cavity, and then injected into the joint cavity for 3 consecutive days. The degeneration of articular cartilage began in 1 week, and a model of middle and late osteoarthritis could be formed in 2 weeks.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a preparation method of an osteoarthritis animal model. The method comprises the following steps: blending a matrix metalloproteinase-3 with normal saline so as to obtain a 5-10nmol/L matrix metalloproteinase-3 solution; blending a urokinase-type plasminogen activator with the normal saline so as to obtain a 2-4nmol/L urokinase-type plasminogen activator solution; then, blending the two solutions in proportion of 3:1 or 2:1 so as to obtain a mixed solution; injecting 0.5mL/kg of mixed solution into an articular cavity of an experimental animal. According to the method, the matrix metalloproteinase-3 and the urokinase-type plasminogen activator which are of conventional chemical reagents in a laboratory are taken as raw materials; the mixture is injected into the articular cavity of the animal, so that the rapid degeneration of cartilage tissues is generated. Thus, the pathogenesis process of osteoarthritis is simulated, thereby bringing great convenience for the research of an osteoarthritis intervention treatment technology. The method has the characteristics of being simple and convenient to operate, rapid in modelling, economical, practical, convenient in material obtainment, and the like.

Description

technical field [0001] The invention relates to a method for preparing an animal model of osteoarthritis. Background technique [0002] Osteoarthritis has become a major bone and joint disease that seriously affects middle-aged and elderly patients around the world. Due to its complex etiology and no clear pathogenesis, it has brought great difficulties to effective clinical treatment. It is now known that matrix metalloproteinases are joint factors of cartilage degeneration in osteoarthritis, and existing studies have shown that the application of matrix metalloproteinase inhibitors can significantly alleviate the process of cartilage degeneration in osteoarthritis. However, in the process of cartilage degeneration in osteoarthritis, the matrix metalloproteinases secreted by chondrocytes and synoviocytes all exist in the form of zymogens, which are mainly activated by urokinase-type plasminogen activator before becoming active enzymes. Cartilage degeneration. [0003] Res...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/54
Inventor 王维山李长俊史晨辉张振东郑伟
Owner 王维山
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products